News 2017-02-17
Porton’s Annual Senior Management Working Conference.
Chongqing,China,February 17,2017: Porton Fine Chemicals, Ltd. held its annual senior management working conference on February 17, 2017. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed the Company’s progress made during 2016 and forward plans for 2017. Oliver Ju and Andrew Xu lauded the efforts of Porton’s employees towards achievement of FY 2016 revenue targets, and summarized the Company’s strategic initiatives for continued growth in FY 2017 and beyond.
Others
More
News 2025-07-31
Porton Participates in Publishing an OPRD Paper, Demonstrating Strength in Drug Synthesis Technology
Metal catalytic and DoE technologies for the optimization of CT1812 synthesis routes

News 2025-07-31
NMPA Approves Jike Shu (Sebaloxavir Marboxil Tablets) for the Treatment of Uncomplicated Influenza in Adults
Self-developed novel PA endonuclease inhibitor anti-influenza drug Jike Shu (Sebaloxavir Marboxil Tablets) has officially received marketing approval from China's National Medical Products Administration (NMPA) for the treatment of uncomplicated influenza in adults.